Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Watch our Latest Symposium on Immuno-centric Approach to Biosimilar and Vaccine Development Check out our Assay List (Method Library)

Scientific Publications

Bioequivalence of Brinzolamide & Brimonidine

Evaluating the Bioequivalence of Brinzolamide & Brimonidine for the treatment of Open-angle Glaucoma

Euglycemic Clamp Study

Comparative evaluation of Pharmacokinetic & Pharmacodynamic properties to assess Insulin Action for Management of Diabetes

Functional Characterization of Abatacept Biosimilar

Veeda’s successful execution of Pharmacodynamic Characterization of Biosimilar to initiate Phase I clinical trials for the treatment of Rheumatoid Arthritis

Pharmacokinetic Bioequivalence Study

Veeda’s successful execution of two-way crossover PK study of Inhalation powder in healthy volunteers

Dermatology Phase I Study

Veeda’s successful execution of a Phase I, double blinded SAD and MAD study in healthy volunteers treating Vitiligo

First to File Study

How we delivered Quality Results for a leading US-based Pharmaceutical Brand in a record period of 12 days

Fresh / Relapsed Multiple Myeloma patients

How we helped an Indian Multinational Pharmaceutical Company reduce Screen Failure Ration significantly

Bioanalytical Aspects of Multiple Myeloma Patient Trial Study

A Multinational pharmaceutical company that specializes in development, manufacturing, and distribution

Quetiapine Fumarate Prolonged Release Tablets

An Indian multinational pharmaceutical company was planning the marketing approval in the EU for Schizophrenic patients.

Handling a complex liposomal molecule – Amphotericin B

A specialty pharmaceutical company based in USA that specializes in development, manufacturing, and Commercialization

Whitepaper on Complex Generics and 505(B)(2) Regulatory Pathways

Gain insights into our capabilities in supporting 505(b)(2) applications and complex generics development

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.